Hui Gyu Park

Hui Gyu Park

Auto-generated profile, based on publicly available information

Hui Gyu Park

Department of Pediatrics, Dell Pediatric Research Institute, University of Texas at Austin, Austin, TX 78723, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
ZWZhen Wang
Zhen Wang
HPHui Gyu Park
Hui Gyu Park
DWDong Hao Wang
Dong Hao Wang
RKRiki Kitano
Riki Kitano
KKKumar Kothapalli
Kumar Kothapalli
JBJ. Thomas Brenna
J. Thomas Brenna

1 January 2018 in Prostaglandins, Leukotrienes and Essential Fatty Acids
Verified
Journal Article
Closed access
HPHui Gyu Park
Hui Gyu Park
MEMatthew Engel
Matthew Engel
KVKyle Vogt-Lowell
Kyle Vogt-Lowell
PLPeter Lawrence
Peter Lawrence
KKKumar Kothapalli
Kumar Kothapalli
JBJ. Thomas Brenna
J. Thomas Brenna

20 July 2022 in Experimental Eye Research
Verified
Journal Article
Closed access
GJGenevieve James
Genevieve James
WBWhitney Bohannan
Whitney Bohannan
EAEniola Adewunmi
Eniola Adewunmi
KSKarsten Schmidt
Karsten Schmidt
HPHui Gyu Park
Hui Gyu Park
JBJ. Thomas Brenna
J. Thomas Brenna

31 March 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
AMAlla Y. Molchanova
Alla Y. Molchanova
SRSvetlana N. Rjabceva
Svetlana N. Rjabceva
TMTigran B. Melik-Kasumov
Tigran B. Melik-Kasumov
NPNikolay B Pestov
Nikolay B Pestov
Plamena R. AngelovaPlamena R. Angelova
Plamena R. Angelova
MSMikhail Shchepinov
Mikhail Shchepinov
Arachidonic acid (ARA) is a major component of lipid bilayers as well as the key substrate for the eicosanoid cascades. ARA is readily oxidized, and its non-enzymatic and enzymatic oxidation products induce inflammatory responses in nearly all tissues, including lung tissues. Deuteration at bis-allylic positions substantially decreases the overall rate of ARA oxidation when hydrogen abstraction is an initiating event. To compare the effects of dosing of arachidonic acid (H-ARA) and its bis-allylic hexadeuterated form (D-ARA) on lungs in conventionally healthy mice and in an acute lung injury model, mice were dosed with H-ARA or D-ARA for six weeks through dietary supplementation and then challenged with intranasal lipopolysaccharide (LPS) for subsequent analysis of bronchoalveolar lavage fluid and lung tissue. Dosing on D-ARA resulted in successful incorporation of D-ARA into various tissues. D-ARA significantly reduced LPS-induced adverse effects on alveolar septal thickness and the bronchoalveolar area. Oral deuterated ARA is taken up efficiently and protects against adverse LPS-induced pathology. This suggests novel therapeutic avenues for reducing lung damage during severe infections and other pathological conditions with inflammation in the pulmonary system and other inflammatory diseases.

21 April 2024 in Cancers
Verified
Journal Article
Open access
PDF file
DSDennis A. Sheeter
Dennis A. Sheeter
SGSecilia Garza
Secilia Garza
HPHui Gyu Park
Hui Gyu Park
LBLorraine-Rana E. Benhamou
Lorraine-Rana E. Benhamou
NBNiharika R. Badi
Niharika R. Badi
JPJohn Powers
John Powers
MYCN amplification (MNA) and disruption of tumor suppressor microRNA (TSmiR) function are key drivers of poor outcomes in neuroblastoma (NB). While MYCN and TSmiRs regulate glucose metabolism, their role in de novo fatty acid synthesis (FAS) and unsaturated FAS (UFAS) remains poorly understood. Here, we show that FAS and UFAS (U/FAS) genes FASN, ELOVL6, SCD, FADS2, and FADS1 are upregulated in high-risk (HR) NB and that their expression is associated with lower overall survival. RNA-Seq analysis of human NB cell lines revealed parallel U/FAS gene expression patterns. Consistent with this, we found that NB-related TSmiRs were predicted to target these genes extensively. We further observed that both MYC and MYCN upregulated U/FAS pathway genes while suppressing TSmiR host gene expression, suggesting a possible U/FAS regulatory network between MYCN and TSmiRs in NB. NB cells are high in de novo synthesized omega 9 (ω9) unsaturated fatty acids and low in both ω6 and ω3, suggesting a means for NB to limit cell-autonomous immune stimulation and reactive oxygen species (ROS)-driven apoptosis from ω6 and ω3 unsaturated fatty acid derivatives, respectively. We propose a model in which MYCN and TSmiRs regulate U/FAS and play an important role in NB pathology, with implications for other MYC family-driven cancers.

9 January 2023 in Foods
Verified
Journal Article
Open access
PDF file
GJGenevieve James
Genevieve James
KSKevin Stephenson
Kevin Stephenson
MCMeghan Callaghan-Gillespie
Meghan Callaghan-Gillespie
MKMohamed Tabita Kamara
Mohamed Tabita Kamara
HPHui Gyu Park
Hui Gyu Park
MMMark Manary
Mark Manary
Ready-to-use therapeutic food (RUTF) is used to treat young children diagnosed with severe acute malnutrition. RUTF with low and balanced linoleic and alpha-linolenic acid, plus omega-3 docosahexaenoic acid (DHA), supports long-term cognitive recovery. DHA is prone to degradation due to peroxidation, possibly exacerbated by the iron inherently in RUTF. Our goals were to prepare benchtop and manufacturing scale of RUTF formulations that include DHA and measure its retention. Twenty-seven RUTF formulas with base ingredients, including oats, high oleic or commodity peanuts, and encapsulated or oil-based DHA at various levels were prepared at benchtop scale, followed by seven months of climate-controlled storage. These pilot samples had similar relative DHA retention. At the manufacturing scale, DHA was added at one of two stages in the process, either at the initial or the final mixing stage. Samples taken at preliminary or later steps show that less than 20% of DHA added at the early stages disappeared prior to packaging for any recipe tested. Overall, our data indicate that most DHA included in RUTF is retained in the final product and that DHA is best retained when added at the latest manufacturing stage.